Vanguard Capital Management’s Phio Pharmaceuticals PHIO Stock Holding History
Bought
Maintained
Sold
Other funds holding PHIO
Vanguard Capital Management's PHIO Position: Q3 2026 in Review
Vanguard Capital Management held its Phio Pharmaceuticals (PHIO) position steady in Q3 2026 at 94,262 shares worth $97.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3851.
Vanguard Capital Management first reported a position in PHIO in Q1 2026 and has held it in 3 quarters since. The position peaked at $97.4K in Q1 2026. 26 funds tracked by Wall St. Rank hold PHIO as of Q3 2026.
- Vanguard Capital Management held 94,262 shares of Phio Pharmaceuticals worth $97.1K as of Q3 2026.
- Vanguard Capital Management left its Phio Pharmaceuticals share count unchanged in Q3 2026.
- Phio Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3851 holding.
- Vanguard Capital Management first reported a position in Phio Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Phio Pharmaceuticals position peaked at $97.4K in Q1 2026.
- 26 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.